A detailed history of Rothschild Investment LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Rothschild Investment LLC holds 10,210 shares of ADPT stock, worth $58,707. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,210
Previous 10,040 1.69%
Holding current value
$58,707
Previous $36.3 Million 43.83%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$3.37 - $5.12 $572 - $870
170 Added 1.69%
10,210 $52.3 Million
Q2 2024

Jul 30, 2024

BUY
$2.34 - $3.96 $23,493 - $39,758
10,040 New
10,040 $36.3 Million
Q4 2023

Jul 31, 2024

SELL
$3.46 - $5.33 $138 - $213
-40 Reduced 0.4%
10,000 $49 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $822M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.